Solu-cortef Injection, Powder, For Solution
Product Images NDC 55154-3942

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Solu-cortef (NDC 55154-3942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

277850a6 771f 4711 A703 10b4c978805e 00

This text panel details Solu-Cortef 100 mg injection powder for solution, hydrocortisone sodium succinate USP, in a 6 x 2 mL Act-O-Vial system. It includes usage instructions for intramuscular or intravenous administration, directions for activating the vial system, storage conditions, dosage form specifics, warnings, and distributor information from Pfizer and Cardinal Health.*

FDA Label Image

Chemical Structure (Solu Cortef 01)

Chemical structure diagram of hydrocortisone sodium succinate, showing the molecular configuration including hydroxyl, ketone, and succinate groups with sodium salt.*

FDA Label Image

Figure (Solu Cortef 02)

An instructional illustration showing the process of drawing fluid from a vial using a syringe. The diagram highlights correct needle and vial alignment, demonstrating proper technique for preparing an injection.*

FDA Label Image

Company Logo (Solu Cortef 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.